CompletedNot Applicable

Prevalence of Oral Side Effects Associated With Chemo and Radiotherapy for Treating Head and Neck Cancer

Egypt294 participantsStarted 2020-10-02

Plain-language summary

A cross-sectional study will be conducted to report oral complications during chemo and radiotherapy treatment in case of patients diagnosed with head and neck cancer and the effect of theses oral side effects on patients' quality of life which will in turn allow the implication of preventive measures

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients after the first week of their treatment till the end of their treatment protocol and at their follow-up visits * patients who completed ESAS questioner * Male and female patients from 20 -70 years old who are diagnosed with head and neck cancer. Exclusion Criteria: * Patients who didn't start their treatment before the examination * Patients who refuse to participate in the study. * Patients with leukemia or blood cell cancers, infants and children

What they're measuring

by ESAS questionnaire ,clinical examination of the patient

Timeframe: through study completion, an average of 1 year

oral mucositis assessed by WHO(world Health Organization) scale, clinical examination

Timeframe: through study completion, an average of 1 year

xerostomia by CODs (Clinical oral dryness scale)

Timeframe: through study completion, an average of 1 year

dysphagia by VHNSS Version 2.0 (Vanderbilt Head and Neck Cancer Symptom Survey)

Timeframe: through study completion, an average of 1 year

pain assessed by numerical rating scale(NRS)

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT04845854

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-20

View on ClinicalTrials.gov More Oral Complications of Chemotherapy and Head and Neck Radiation trials

Plain-language summary

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

by ESAS questionnaire ,clinical examination of the patient

Timeframe: through study completion, an average of 1 year

oral mucositis assessed by WHO(world Health Organization) scale, clinical examination

Timeframe: through study completion, an average of 1 year

xerostomia by CODs (Clinical oral dryness scale)

Timeframe: through study completion, an average of 1 year

dysphagia by VHNSS Version 2.0 (Vanderbilt Head and Neck Cancer Symptom Survey)

Timeframe: through study completion, an average of 1 year

pain assessed by numerical rating scale(NRS)

Timeframe: through study completion, an average of 1 year